Skip to main content
. 2021 Jun 28;13(13):3223. doi: 10.3390/cancers13133223

Table 2.

Molecular features of TCGA THCA according to ECM1 expression status.

Molecular Feature ECM1 p Value
Low Expression
n = 124 (%)
High Expression
n = 124 (%)
mRNA cluster number
1 58 (47.9) 51 (43.2) 0.190
2 7 (5.8) 21 (17.8)
3 36 (29.8) 5 (4.2)
4 5 (4.1) 14 (11.9)
5 15 (12.4) 27 (22.9)
miRNA cluster number
1 3 (2.5) 3 (2.4) 0.796
2 16 (13.1) 22 (17.9)
3 24 (19.7) 11 (8.9)
4 46 (37.7) 51 (41.5)
5 19 (15.6) 21 (17.1)
6 14 (11.5) 15 (12.2)
RAS mutation
Absent 117 (95.1) 90 (73.2) <0.0001
Present 6 (4.9) 33 (26.8)
BRAF mutation
Absent 71 (57.7) 92 (74.8) 0.005
Present 52 (42.3) 31 (25.2)
TERT promoter mutation
Absent 91 (95.8) 78 (84.8) 0.011
Present 4 (4.2) 14 (15.2)
RAS/RAF score 0.01 ± 0.81 0.07 ± 0.68 0.533 *
ERK score −5.25 ± 23.26 4.92 ± 19.35 0.001 *
Differentiation score 0.32 ± 1.37 0.39 ± 1.00 0.674 *
Akt pT308 0.09 ± 0.54 0.06 ± 0.35 0.691 *
Akt pS473 0.14 ± 0.66 0.01 ± 0.46 0.122 *

TCGA, The Cancer Genome Atlas; THCA, thyroid carcinoma.  p values calculated by Student’s t test; * p values calculated by chi-square test or linear-by-linear association.